https://pharmato.ai 2026-04-05T17:39:30.362Z https://pharmato.ai/blog 2026-04-05T17:39:30.362Z https://pharmato.ai/pricing 2026-04-05T17:39:30.362Z https://pharmato.ai/consulting 2026-04-05T17:39:30.362Z https://pharmato.ai/calendar 2026-04-05T17:39:30.362Z https://pharmato.ai/blog/oral-glp-1-clinical-comparison-novo-nordisks-oral-semaglutide-vs-eli-lillys-orforglipron 2026-04-05T05:42:00.000Z https://pharmato.ai/blog/poster-cr5-inhibition-with-the-human-monoclonal-antibody-leronlimab-enhances-temozolomide-and-radiation-induced-killing-of-glioblastoma-multiforme-cells 2026-04-02T10:02:00.000Z https://pharmato.ai/blog/united-therapeutics-breakthrough-phase-3-results-of-tyvaso-in-idiopathic-pulmonary-fibrosis 2026-03-31T09:35:00.000Z https://pharmato.ai/blog/biogen-litifilimab-phase-2-trial-meets-primary-endpoint-in-cutaneous-lupus-erythematosus 2026-03-30T14:31:00.000Z https://pharmato.ai/blog/rocket-pharmaceuticals-rcktnasdaq-approaches-pdufa-decision-for-kresladi 2026-03-26T14:39:00.000Z https://pharmato.ai/blog/pharmato-integras-free-access-boost-new-drug-intelligence-efficiency-by-10x 2026-03-26T13:12:00.000Z https://pharmato.ai/blog/efficiently-building-a-competitive-intelligence-landscape-for-new-drug-pipelines 2026-03-26T13:04:00.000Z https://pharmato.ai/blog/shionogi-buys-out-joint-venture-for-150-million-to-tap-into-the-10-billion-osa-blue-ocean-market 2026-03-26T13:01:00.000Z https://pharmato.ai/blog/sanofi-returns-to-tce-arena-with-123b-acquires-kalis-trispecific-antibody-kt501-1 2026-03-26T13:01:00.000Z https://pharmato.ai/blog/united-therapeutics-ralinepag-achieves-phase-3-success-in-pulmonary-arterial-hypertension 2026-03-03T08:21:00.000Z